CFTR and cystic fibrosis: Integration and splicing of an SE23–27 is attractive as it has the potential to correct any variant occurring in the last 5 exons of CFTR (currently W1282X and 92 other CF-causing variants accounting for ~4.5% of people with CF, see Supplementary Material, Table S2).